Antimicrob Agents Chemother
- MORAN-BARRIO J, Giacone L, Brambilla L, Fabbri C, et al
The lipoprotein biosynthesis pathway: key to OXA-mediated carbapenem resistance
in Acinetobacter baumannii.
Antimicrob Agents Chemother. 2025 Nov 4:e0109925. doi: 10.1128/aac.01099.
- HE G, Zeng S, Banki LT, Zhou W, et al
Clinical emergence of inducible macrolide resistance mediated by acquired erm(41)
C28T mutation in Mycobacterium abscessus.
Antimicrob Agents Chemother. 2025 Nov 6:e0115325. doi: 10.1128/aac.01153.
- FINDLAY J, Nordmann P, Jayol A, Seth-Smith HMB, et al
Carbapenem resistance in a Klebsiella quasipneumoniae isolate resulting from
production of CTX-M-33 and OmpK36 porin deficiency.
Antimicrob Agents Chemother. 2025 Nov 6:e0121425. doi: 10.1128/aac.01214.
- LODISE TP, Min J, Nathanson BH, Yucel E, et al
Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based
therapy of pneumonia due to MDR Pseudomonas aeruginosa (PUMA).
Antimicrob Agents Chemother. 2025;69:e0056925.
- WANG C, Feng Y, Zong Z
Colistin heteroresistance in Enterobacter due to base heterozygosity at certain
phoP and phoQ locations.
Antimicrob Agents Chemother. 2025;69:e0071325.
- KUNZ COYNE AJ, Gray R, May E, Curry H, et al
Molecular and pharmacodynamic insights into beta-lactam therapy for high-inoculum
Enterobacter cloacae complex infections.
Antimicrob Agents Chemother. 2025;69:e0117025.
- RAMIREZ D, Ramirez DM, Arora R, Arthur G, et al
Noncytotoxic polymyxin derivatives enhance antibiotic action against
multidrug-resistant Gram-negative bacteria.
Antimicrob Agents Chemother. 2025;69:e0071225.
- MASSIC L, Doorley LA, Jones SJ, Richardson I, et al
Acquired amphotericin B resistance attributed to a mutated ERG3 in Candidozyma
auris.
Antimicrob Agents Chemother. 2025;69:e0060125.
- SHINOHARA T, Wada A, Abe M, Oiki S, et al
A zinc-chelating cyclic alkyl polyamine compound is efficient and safe in a
murine model of multidrug-resistant Candida auris infection.
Antimicrob Agents Chemother. 2025 Sep 26:e0085625. doi: 10.1128/aac.00856.
- WIEDERHOLD NP
Case Commentary: Successful use of olorofim for the treatment of
multi-drug-resistant Lomentospora prolificans infection in a child.
Antimicrob Agents Chemother. 2025;69:e0107225.
- VENA A, Bartalucci C, Muccio M, Tiseo G, et al
Comparative effectiveness of echinocandins and liposomal amphotericin B for
fluconazole-resistant Candida parapsilosis bloodstream infections.
Antimicrob Agents Chemother. 2025 Sep 30:e0035525. doi: 10.1128/aac.00355.
- ALVARADO CASAS ML, Triana Diaz JA, Montilla-Escudero E, Prada Cardozo DA, et al
Genomic epidemiology of Colombian resistant Candida auris isolates.
Antimicrob Agents Chemother. 2025 Oct 7:e0072525. doi: 10.1128/aac.00725.
- XUE R, Gao S, de Hoog S, van Diepeningen A, et al
Olorofim activity against multidrug-resistant Fusarium unveils intra-species and
inter-species variability.
Antimicrob Agents Chemother. 2025;69:e0096125.
Infect Control Hosp Epidemiol
- SCHECHNER V, Efrati-Epchtien R, Cohen A, Temkin E, et al
Transmission of carbapenem-resistant Acinetobacter baumannii in post-acute care
hospitals: an FTIR-based analysis of strain similarity.
Infect Control Hosp Epidemiol. 2025 Nov 4:1-7. doi: 10.1017/ice.2025.10337.
- WU H, England R, Huang X, Lutgring J, et al
Concise communication title: wide adoption of rapid molecular detection of
antimicrobial resistance markers for use with blood cultures: implications for
national surveillance of antimicrobial resistance.
Infect Control Hosp Epidemiol. 2025 Nov 6:1-4. doi: 10.1017/ice.2025.
- WILLIAMS V, Chevrier J, Elligsen M, Lam PW, et al
Antibiotic-exposure guided prevalence screening for vancomycin-resistant
Enterococcus: better value for hospitals.
Infect Control Hosp Epidemiol. 2025 Nov 4:1-2. doi: 10.1017/ice.2025.10332.
- LEE PS, OYong K, Shah AN, Thiel C, et al
Environmental and human health impact of contact precaution use for
methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus
in Los Angeles County.
Infect Control Hosp Epidemiol. 2025 Nov 7:1-3. doi: 10.1017/ice.2025.10338.
J Infect Chemother
- JUNG J, Kim YK, Chang E, Bae S, et al
Corrigendum to 'The origin of sequence type 72 community-associated
methicillin-resistant Staphylococcus aureus (MRSA) and fusidic acid (FA)
resistant sequence type 5 MRSA: Analysis of FA resistance and spa type in a
single center in South Korea'[Jour
J Infect Chemother. 2025 Oct 30:102847. doi: 10.1016/j.jiac.2025.102847.
J Infect Dis
- JIANG JH, Lim CX, Lai X, Kostoulias X, et al
Daptomycin-Loaded Nanocarriers Facilitate Synergistic Killing of
Methicillin-Resistant Staphylococcus aureus via Lipid-Mediated Interactions and
Targeting.
J Infect Dis. 2025 Nov 4:jiaf492. doi: 10.1093.
J Med Microbiol
- HUYNH T, Lam T, Pham N, Luong L, et al
Mathematical modelling of synergistic triple-antibiotic therapy against
carbapenem-resistant Acinetobacter baumannii at clinically achievable
concentrations.
J Med Microbiol. 2025;74.
PLoS Med
- WATERLOW NR, Chandler CIR, Cooper BS, Moore CE, et al
Combining demographic shifts with age-based resistance prevalence to estimate
future antimicrobial resistance burden in Europe and implications for targets: A
modelling study.
PLoS Med. 2025;22:e1004579.
PLoS One
- LIAO C, Peng J, Luo S, Xie X, et al
Antimicrobial multidrug resistance of Escherichia coli from broiler farms in
Zhanjiang, China.
PLoS One. 2025;20:e0335518.
Proc Natl Acad Sci U S A
- HU L, Zhang A, Warshel A
Exploring evolutionary trajectories of drug resistance.
Proc Natl Acad Sci U S A. 2025;122:e2517715122.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016